The use of 2-DG has disclosed the central function of glucose metabolism in bacterial and viral infection by showing in the latter model the lethality associated with 2-DG treatment by a mechanism involving type I IFN signaling and Ddit3/CHOP (23). This evidence concerns the gene DDIT3 and viral infectious disease.